XPO1 Inhibition Enhances Radiation Response in Preclinical Models of Rectal Cancer. [electronic resource]
Producer: 20161219Description: 1663-73 p. digitalISSN:- 1557-3265
- Animals
- Apoptosis -- drug effects
- Cell Line, Tumor
- Combined Modality Therapy
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Humans
- Hydrazines -- pharmacology
- Inhibitor of Apoptosis Proteins -- metabolism
- Karyopherins -- antagonists & inhibitors
- Mice
- Radiation
- Radiation Tolerance -- drug effects
- Radiation-Sensitizing Agents -- pharmacology
- Receptors, Cytoplasmic and Nuclear -- antagonists & inhibitors
- Rectal Neoplasms -- metabolism
- Triazoles -- pharmacology
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
- Exportin 1 Protein
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.